Kristin Abate, Chief Accounting Officer: Karyopharm Therapeutics KPTI Sell · Filed 25/07/23

Trade details

Type: Insider sale
Amount: $952
Shares · price: 238 sh · $4.00 a share
Held after: 9,475 sh
Stock: Karyopharm Therapeutics KPTI
Person: Kristin AbateChief Accounting Officer
Trade date: 25/07/22
Filed: 25/07/23
Days to filing: 1 days

Sold 2.5% of holdings

Share of holding sold: 2.5%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/22~25/08/21

Kristin Abate's recent trades

Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$504
53 sh
$504
Filed 05/15
Traded 05/14
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$5,260
559 sh
$5,260
Filed 03/03
Traded 03/02
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$352
50 sh
$352
Filed 01/29
Traded 01/28
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$1,579
265 sh
$1,579
Filed 01/22
Traded 01/21
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,281
362 sh
$2,281
Filed 25/10/03
Traded 25/10/01

Kristin Abate, CAO — sold $952 of Karyopharm Therapeutics KPTI · 2.5% of holdings | Whalegun